Exact Mass: 389.0987

Exact Mass Matches: 389.0987

Found 44 metabolites which its exact mass value is equals to given mass value 389.0987, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefprozil

(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C18H19N3O5S (389.1045)


Cefprozil is only found in individuals that have used or taken this drug. It is a cephalosporin antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections.Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   

Indibulin

2-{1-[(4-chlorophenyl)methyl]-1H-indol-3-yl}-2-oxo-N-(pyridin-4-yl)acetamide

C22H16ClN3O2 (389.0931)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

Brisoral

7-{[2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C18H19N3O5S (389.1045)


   
   

Azoxystrobin acid

Azoxystrobin acid

C21H15N3O5 (389.1012)


An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 1-carboxy-2-methoxyethenyl substituent, also at C-2. It is a metabolite of the fungicidal agrochemical azoxystrobin. CONFIDENCE standard compound; INTERNAL_ID 2031

   
   

CAY10566

3-[4-(2-chloro-5-fluorophenoxy)-1-piperidinyl]-6-(5-methyl-1,3,4-oxadiazol-2-yl)-pyridazine

C18H17ClFN5O2 (389.1055)


CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively. CAY10566 also shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM)[1][2].

   

Natural Yellow 18

16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride;hydrate

C20H20ClNO5 (389.103)


Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

   

Azoxystrobin (free acid)

Azoxystrobin (free acid)

C21H15N3O5 (389.1012)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 2734

   
   

6-Hydroxyondansetron sulfate

6-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   

7-Hydroxyondansetron sulfate

7-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   

8-Hydroxyondansetron sulfate

8-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol,5b,6,7,12b,13,14-hexahydro-13-methyl-, hydrochloride (1:1), (5bR,6S,12bS)-

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol,5b,6,7,12b,13,14-hexahydro-13-methyl-, hydrochloride (1:1), (5bR,6S,12bS)-

C20H20ClNO5 (389.103)


   

Ostarine D4

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   

Ostarine

Enobosarm

C19H14F3N3O3 (389.0987)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen

   
   

protopine hydrochloride

protopine hydrochloride

C20H20ClNO5 (389.103)


   

Cefprozil IMpurity C

Cefprozil IMpurity C

C18H19N3O5S (389.1045)


   

((Methylimino)diethylene)bis(ethyldimethylammonium bromide)

((Methylimino)diethylene)bis(ethyldimethylammonium bromide)

C13H33Br2N3 (389.1041)


   
   

Indeglitazar

Indeglitazar

C19H19NO6S (389.0933)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Indeglitazar (PPM 204) is an orally available PPAR pan-agonist for all three PPARα, PPARδ and PPARγ[1].

   

Metoclopramide dihydrochloride monohydrate

Metoclopramide dihydrochloride monohydrate

C14H26Cl3N3O3 (389.104)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

Acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester

Acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester

C21H15N3O5 (389.1012)


   

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   

N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide

N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide

C20H15N5O2S (389.0946)


   

2-[(1r)-1-Carboxy-2-Naphthalen-1-Ylethyl]-1,3-Dioxo-2,3-Dihydro-1h-Isoindole-5-Carboxylic Acid

2-[(1r)-1-Carboxy-2-Naphthalen-1-Ylethyl]-1,3-Dioxo-2,3-Dihydro-1h-Isoindole-5-Carboxylic Acid

C22H15NO6 (389.0899)


   

(6s)-1-Chloro-3-[(4-Fluorobenzyl)oxy]-6-(Pyrrolidin-1-Ylcarbonyl)pyrrolo[1,2-A]pyrazin-4(6h)-One

(6s)-1-Chloro-3-[(4-Fluorobenzyl)oxy]-6-(Pyrrolidin-1-Ylcarbonyl)pyrrolo[1,2-A]pyrazin-4(6h)-One

C19H17ClFN3O3 (389.0942)


   

(2e,3e)-4-(2-Aminoethoxy)-2-[({3-Hydroxy-2-Methyl-5-[(Phosphonooxy)methyl]pyridin-4-Yl}methyl)imino]but-3-Enoic Acid

(2e,3e)-4-(2-Aminoethoxy)-2-[({3-Hydroxy-2-Methyl-5-[(Phosphonooxy)methyl]pyridin-4-Yl}methyl)imino]but-3-Enoic Acid

C14H20N3O8P (389.0988)


   

Indibulin

Indibulin

C22H16ClN3O2 (389.0931)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   
   

7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C18H19N3O5S (389.1045)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(4E)-4-[2-(2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

(4E)-4-[2-(2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

C18H17N2O8+ (389.0985)


   

Brisoral

(Z)-Cefprozil

C18H19N3O5S (389.1045)


A semisynthetic, second-generation cephalosporin, with prop-1-enyl and (R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used to treat bronchitis as well as ear, skin and other bacterial infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline

N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline

C20H18F2NO3P (389.0992)


   

N-(1,3-benzodioxol-5-ylmethyl)-6-(2-chlorophenyl)-4-quinazolinamine

N-(1,3-benzodioxol-5-ylmethyl)-6-(2-chlorophenyl)-4-quinazolinamine

C22H16ClN3O2 (389.0931)


   

2-(4-chlorophenyl)-N-[[2-(4-morpholinyl)anilino]-sulfanylidenemethyl]acetamide

2-(4-chlorophenyl)-N-[[2-(4-morpholinyl)anilino]-sulfanylidenemethyl]acetamide

C19H20ClN3O2S (389.0965)


   

4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide dihydrochloride monohydrate

4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide dihydrochloride monohydrate

C14H26Cl3N3O3 (389.104)


   

2-{[(5-amino-5-carboxy-1-hydroxypentylidene)amino](carboxy)methyl}-5-formyl-3,6-dihydro-2h-1,3-thiazine-4-carboxylic acid

2-{[(5-amino-5-carboxy-1-hydroxypentylidene)amino](carboxy)methyl}-5-formyl-3,6-dihydro-2h-1,3-thiazine-4-carboxylic acid

C14H19N3O8S (389.0893)


   

2-{1-acetyl-5-hydroxy-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzoic acid

2-{1-acetyl-5-hydroxy-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzoic acid

C22H15NO6 (389.0899)


   

(2s)-2-carboxy-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

(2s)-2-carboxy-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

[C18H17N2O8]+ (389.0985)


   

1-methyl-18-oxa-7,10,11-triazahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6,14,17(24),19-hexaene-5,12,16,21-tetrone

1-methyl-18-oxa-7,10,11-triazahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6,14,17(24),19-hexaene-5,12,16,21-tetrone

C21H15N3O5 (389.1012)